Clinical trials
Phase 1 Endometrial Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exelixis | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| BioNTech Cell & Gene Therapies GmbH | 1 |
| Novartis Pharmaceuticals | 1 |
| Radboud University Medical Center | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 9 |
| Ovarian Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Uterine Cervical Neoplasms | 4 |
| Stomach Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.